Master in Implant Dentistry, University of Seville, Seville, Spain; Master's Degree in Family and Community Dentistry, University of Seville, Seville, Spain; Collaborating Professor of the Master's Degree in Family and Community Dentistry, University of Seville, Seville, Spain.
Department of Clinical Dental Specialties, Faculty of Dentistry, Complutense University of Madrid, Madrid, Spain.
J Stomatol Oral Maxillofac Surg. 2022 Feb;123(1):74-80. doi: 10.1016/j.jormas.2021.01.011. Epub 2021 Jan 22.
Since the beginning of Oral Implantology, preventive antibiotic therapy has been routinely prescribed. However, at present, due to the growing appearance of antimicrobial resistance, its use has been questioned, generating a great debate and an emerging controversy. The present systematic review aims to analyze the scientific literature to determine whether the preventive prescription of antibiotics in augmentation procedures with the insertion of implants in one or two phases decreases the incidence of postoperative infections and/or the survival rate of the implants.
The MEDLINE database was searched (via PubMed) with the following keywords: (bone grafting OR alveolar ridge augmentation OR bone graft augmentation OR guided bone regeneration OR bone block) AND (dental implants OR dental implant OR oral implantology) AND (antibiotic prophylaxis OR antibiotics). The criteria used were those described by the PRISMA® Statement. The search was limited to randomised clinical trials, systematic reviews and meta-analyses published in the last 15 years (2005-2020).
After reading the titles and abstracts of the resulting articles, only one systematic review meeting the described criteria and 4 randomised clinical trials were included.
Prescription of 2 or 3 g of amoxicillin one hour before surgery is recommended to reduce the early failure rate of one-stage implants and to decrease the bacterial load of grafted bone particles in bone augmentation procedures with one or two-stage implants.
自口腔种植学诞生以来,预防性抗生素治疗已常规应用。然而,目前由于抗菌药物耐药性的日益显现,其应用受到质疑,引发了广泛的争论和争议。本系统评价旨在分析科学文献,以确定在一期或二期植入物植入的骨增量术中预防性应用抗生素是否能降低术后感染的发生率和/或种植体的存活率。
通过 MEDLINE 数据库(通过 PubMed)检索以下关键词:(骨移植术 OR 牙槽嵴增高术 OR 骨增量术 OR 引导骨再生术 OR 骨块移植术)和(牙种植体 OR 种植牙 OR 口腔种植学)和(抗生素预防 OR 抗生素)。使用的标准是 PRISMA®声明中描述的标准。检索范围限于过去 15 年(2005-2020 年)发表的随机临床试验、系统评价和荟萃分析。
在阅读了相关文章的标题和摘要后,仅纳入了 1 篇符合描述标准的系统评价和 4 项随机临床试验。
建议在手术前 1 小时使用 2 或 3g 阿莫西林,以降低一期植入物的早期失败率,并降低一期或二期植入物骨增量术中移植骨颗粒的细菌负荷。